Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362

Partial Redetermination of the Fe-W Phase Diagram

International audienceThe objective of the current study is to perform a careful investigation of the (Fe) and (W) solvus and of the intermetallic compounds in the Fe-W system as it could have a significant impact on higher-order systems based on this binary system. Two key alloys, Fe-14 at. pct W and Fe-50 at. pct W, and a diffusion couple were synthesized based on the literature. They were studied by long time annealing experiments with a selected heat treatment route, X-Ray diffraction analysis, and electron microprobe analysis with a careful control of impurity levels of C, Si, and O. The two intermetallic phases mu-Fe7W6 and lambda-Fe2W are characterized and the composition range of the mu-Fe7W6 phase is specified. The phase previously reported as FeW is most probably a ternary carbide with low carbon content. An accurate determination of the solubility of W in alpha Fe and of Fe in alpha W is presented

A DYNAMIC FRACTURE ANALYSIS OF CRACK CURVING AND BRANCHING

On présente un critère de courbure de fissure fondé sur sa stabilité directionnelle ainsi qu'un critère de ramification nécessitant un facteur dynamique d'intensité de contrainte de ramification et le critère de courbure. Ces critères sont utilisés pour prédire les courbures et les ramification de fissures dans des échantillons de Homalite-100, de polycarbonate, d'acier et de tubes d'aluminium.A crack curving criterion based on its directional stability and a crack branching criterion requiring a dynamic branching stress intensity factor and the crack curving criterion are presented. These criteria are used to predict crack curvings and crack branchings in Homalite-100 and polycarbonate fracture specimens, and bursting steel and aluminum pipes